Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Depreciation and Depletion (2016 - 2025)

Immucell's Depreciation and Depletion history spans 16 years, with the latest figure at $701539.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 4.85% year-over-year to $701539.0; the TTM value through Dec 2025 reached $2.7 million, up 1.59%, while the annual FY2025 figure was $2.7 million, 1.59% up from the prior year.
  • Depreciation and Depletion reached $701539.0 in Q4 2025 per ICCC's latest filing, up from $674314.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $701539.0 in Q4 2025 to a low of $596424.0 in Q4 2021.
  • Average Depreciation and Depletion over 5 years is $649349.4, with a median of $662966.0 recorded in 2024.
  • Peak YoY movement for Depreciation and Depletion: grew 11.78% in 2023, then dropped 3.64% in 2024.
  • A 5-year view of Depreciation and Depletion shows it stood at $596424.0 in 2021, then grew by 0.51% to $599479.0 in 2022, then increased by 11.78% to $670109.0 in 2023, then decreased by 0.15% to $669072.0 in 2024, then increased by 4.85% to $701539.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Depreciation and Depletion are $701539.0 (Q4 2025), $674314.0 (Q3 2025), and $663455.0 (Q2 2025).